Back to results
US 5,686,480 AGranted
Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
AssigneeMerck Sharp & Dohme Corp.
InventorsIan James Collins, Paul David Leeson, Michael Rowley
Life of this patent
Estimating the term…
Abstract
A class of fused tricyclic heteroaromatic compounds of formula (I), or a salt thereof or a prodrug thereof containing a fused pyrazole ring are ligands for dopamine receptor subtypes within the body and are therefore of use in the treatment and/or prevention of disorders of the dopamine system, such as schizophrenia.
Claims6
A compound of formula I, or a pharmaceutically acceptable salt thereof or a prodrug thereof:
- ##STR12## wherein the broken circle represents two non-adjacent double bonds whereby the five-membered ring containing X and Y is aromatic;
- one of X and Y represents nitrogen, and the other of X and Y represents N--R.sup.2 ;
- Z represents a chemical bond, an oxygen or sulphur atom, or a methylene group;
- Q represents a moiety selected from the group consisting of a moiety of formulae Qa, Qb, Qc and Qd:
- ##STR13## in which the broken line represents an optional chemical bond;
- V represents an oxygen atom or a moiety of formula N--R.sup.7 ;
- R.sup.6 represents hydrogen, or an optionally substituted C.sub.1-6 alkyl, C.sub.1-6 alkoxy, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-7 cycloalkyl, C.sub.3-7 cycloalkyl(C.sub.1-6)alkyl, aryl, aryl(C.sub.1-6)alkyl, aryl(C.sub.1-6)alkoxy, aryl(C.sub.2-6)alkenyl, aryl(C.sub.2-6)alkynyl, C.sub.3-7 heterocycloalkyl(C.sub.1-6)alkyl, heteroaryl, heteroaryl(C.sub.1-6)alkyl, heteroaryl(C.sub.2-6)alkenyl or heteroaryl(C.sub.2-6)alkynyl group, wherein aryl is selected from phenyl or naphthyl and heteroaryl is selected from the group consisting of pyridyl, quinolyl, isoquinolyl, pyridazinyl, pyrimidinyl, pyrazinyl, pyranyl, furyl, benzofuryl, dibenzofuryl, thienyl, benzthienyl, indolyl, imidazolyl, oxadiazolyl and thiadiazolyl;
- R.sup.7 represents an optionally substituted C.sub.1-6 alkyl, C.sub.1-6 alkoxy, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-7 cycloalkyl, C.sub.3-7 cycloalkyl(C.sub.1-6)alkyl, aryl, aryl(C.sub.1-6)alkyl, aryl(C.sub.1-6)alkoxy, aryl(C.sub.2-6)alkenyl, aryl(C.sub.2-6)alkynyl, C.sub.3-7 heterocycloalkyl(C.sub.1-6)alkyl, heteroaryl, heteroaryl(C.sub.1-6)alkyl, heteroaryl(C.sub.2-6)alkenyl or heteroaryl(C.sub.2-6)alkynyl group, wherein aryl and heteroaryl are defined above;
- W represents --CH.sub.2 -- or --CH.sub.2 CH.sub.2 --;
- and
- R.sup.8 represents hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, aryl, aryl(C.sub.1-6)alkyl, or halogen;
- R.sup.1 and R.sup.2 independently represent hydrogen or C.sub.1-6 alkyl;
- R.sup.3, R.sup.4 and R.sup.5 independently represent hydrogen, hydrocarbon, a heterocyclic group, halogen, cyano, trifluoromethyl, nitro, --OR.sup.a, --SR.sup.a, --SOR.sup.a, SO.sub.2 R.sup.a, --SO.sub.2 NR.sup.a R.sup.b, --NR.sup.a R.sup.b, --NR.sup.a COR.sup.b, --NR.sup.a CO.sub.2 R.sup.b, --COR.sup.a, --CO.sub.2 R.sup.a or --CONR.sup.a R.sup.b ;
- and
- R.sup.a and R.sup.b independently represent hydrogen, hydrocarbon or a heterocyclic group.
12 more elements
A compound selected from:
- 3-4-(4-methoxyphenyl)piperazin-1-ylmethyl!-4,5-dihydro-1H-benzog!indazole ;
- 3-4-(5-chloropyridin-2-yl)piperazin-1-ylmethyl!-4,5-dihydro-1H-benzog!ind azole;
- 3-(1,2,3,4-tetrahydroisoquinolin-2-ylmethyl)-4,5-dihydro-1H-benzog!indazol e;
- 3-4-(isoquinolin-3-yl)piperazin-1-ylmethyl!-4,5-dihydro-1H-benzog!indazol e;
- 3-(4-phenyl-1,2,3,6-tetrahydropyridin-1-ylmethyl)-4,5-dihydro-1H-benzog!in dazole;
- 3-4-(2-(furan-2-yl)ethyl)-1,2,3,6-tetrahydropyridin-1-ylmethyl!-4,5-dihydr o-1H-benzog!indazole;
- 3-4-(2-phenylethyl)-1, 2,3,6-tetrahydropyridin-1-ylmethyl!-4,5-dihydro-1H-benzog!indazole;
- 3-(4-phenylpiperidin-1-ylmethyl)-4,5-dihydro-1H-benzog!indazole;
- 3-(4-benzylpiperazin-1-ylmethyl)-4,5-dihydro-1H-benzog!indazole;
- 3-4-(quinolin-2-yl)piperazin-1-ylmethyl!-4,5-dihydro-1H-benzog!indazole;
- 3-4-((E)-2-phenylethenyl)-1,2,3,6-tetrahydropyridin-1-ylmethyl!-4,5-dihydr o-1H-benzog!indazole;
- 3-4-(4-methoxyphenyl)piperazin-1-ylmethyl!-1,4-dihydroindeno1,2-c!pyrazol e;
- 3-4-(4-methoxyphenyl)piperazin-1-ylmethyl!benzob!-2H-pyrano4,3-c!-1H-pyr azole;
- pharmaceutically acceptable and salts and prodrugs thereof.
11 more elements
Dependencies are inferred from the claim text.